ParenteralDosed ingredient Cosmetic cross-reference

Colfosceril Palmitate

CAS 63-89-8

Colfosceril Palmitate (CAS 63-89-8) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

2

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Colfosceril Palmitate

CAS Number

63-89-8

UNII

319X2NFW0A

InChIKey

KILNVBDSWZSGLL-KXQOOQHDSA-N

ChEMBL ID

CHEMBL1200737

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

dosed ingredientnatural productparenteral

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)

Approved or marketed human pharmaceutical use is represented in the source phase field.

ChEMBL CHEMBL1200737 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	AC50	30000 nM	30	-
-	Potency	1066.55 nM	2	-

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
COLFOSCERIL PALMITATE	69782	SU	MTHSPL
colfosceril palmitate	69782	PIN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Colfosceril Palmitate used for in pharmaceutical contexts?

Colfosceril Palmitate (CAS 63-89-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Colfosceril Palmitate?

No adverse-event association or SIDER side-effect rows are rendered for Colfosceril Palmitate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Colfosceril Palmitate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Dipalmitoyl Glycerophosphocholine (DPPC) with EU status "permitted".

What clinical phase is Colfosceril Palmitate in?

Colfosceril Palmitate is rendered with ChEMBL max phase 4 (approved).